WS20.02 Input supporting a young person with increased cough suppression in the context of COVID-19

por Shayle, A., Lock, K.
Publicado 2022

ePS1.02 Long-term psychological impact of COVID-19 on adult patients with cystic fibrosis, including transplanted patients

por Havermans, T., Seyen, N., Luyckx, K., Vos, R., Dupont, L.
Publicado 2022

P245 Kaftrio® Impact and Side-effect Survey (KISS)

por Holden, A., Thickett, K., Sammons, L., Bird, K., Fitch, G., MacDuff, N.
Publicado 2022

ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis

por Alicandro, G., Dacco’, V., Cariani, L., Contarini, M., Rosazza, C., Sciarrabba, C.S., Ferraro, F., Orena, B.S., Colombo, C.
Publicado 2022

ePS4.09 COVID-19 vaccination in households of paediatric cystic fibrosis patients - experience of The Cystic Fibrosis Centre in Zagreb, Croatia

por Bambir, I., Todoric, I., Omerza, L., Milinkovic, T., Markelic, I., Palkovic, T. Odobasic, Dugac, A. Vukic, Tjesic-Drinkovic, D.
Publicado 2022

P054 Severity of COVID-19 infection in cystic fibrosis patients compared to the general population

por Rosazza, C., Medino, P., Bandera, A., Boraso, M.S., Ciciriello, F., Cipolli, M., Galietta, L.J., Gramegna, A., Itri, T., Lucidi, V., Biffi, A., Alicandro, G., Colombo, C.
Publicado 2022

ePS4.07 COVID-19 early vaccination campaign in Italian cystic fibrosis (CF) patients: the experience of the Italian Society for the Study of Cystic Fibrosis (SIFC)

por Lucca, F., Carnovale, V., Casciaro, R., Comello, I., Daccò, V., Ferrara, E., Francalanci, M., Gramegna, A., Lucanto, M.C., Maschio, M., Messore, B., Pisi, G., Poli, P., Pradal, U., Rotolo, N., Salvatore, D., Vitullo, P., Cipolli, M.
Publicado 2022

ePS4.03 Outcomes of COVID-19 in patients with cystic fibrosis in Wales, UK

por Lau, D., Speight, L., Melindo, F., Prosser, A., Lee, J., Addy, C., Duckers, J., Ketchell, I.
Publicado 2022

P074 Post-COVID-19 condition in children with cystic fibrosis

por Chernyavskaya, A., Simonova, O.
Publicado 2022

WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells

por Lotti, V., Merigo, F., Lagni, A., Di Clemente, A., Ligozzi, M., Bernardi, P., Rossini, G., Concia, E., Plebani, R., Romano, M., Sbarbati, A., Sorio, C., Gibellini, D.
Publicado 2022

ePS5.01 Cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity

por Lausen, M., Øbro, N.F., Nielsen, B.U., Møller, R., Rossi, E., Marquart, H.V., Ostrowski, S.R., Skov, M., Pressler, T., Molin, S., Johansen, H.K.
Publicado 2022

ePS5.02 Effect of omalizumab on glucocorticoid use and lung function in the treatment of allergic bronchopulmonary aspergillosis in people with cystic fibrosis: a systematic review...

por Elborn, J.S., Jin, M., Douglass, J.A., Calhoun, W.J., Agarwal, R., Lazarewicz, S., Yan, M.
Publicado 2022

ePS4.10 Evaluation of possible adverse events in relationship to the SARS-CoV-2 vaccination in cystic fibrosis patients with or without lung transplantation: a retrospective single...

por Gautschi, F., Hage, R., Steinack, C., Schuurmans, M.M.
Publicado 2022

P079 Real-life data on the efficacy and safety of tezacaftor/ivacaftor in people living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual func...

por Vincken, S., Knoop, C., Verbanck, S., Buyck, N., Vanderhelst, E.
Publicado 2022

P072 SARS-CoV-2 infection in patients with cystic fibrosis (CF) - a single centre experience

por Vidoevska, A., Jakovska, T., Momchilovik, S., Arnaudova-Danevska, I., Ginovska-Tasevska, E.
Publicado 2022

ePS1.05 Impact of COVID-19 on mental health among people with cystic fibrosis

por Chrysochoou, E.-A., Hatziagorou, E., Michailidou, C., Gioulvanidou, M., Galogavrou, M., Tsanakas, J.
Publicado 2022

P075 COVID-19 vaccination uptake in patients with cystic fibrosis

por Manning, D.-E., Speight, L., Prosser, A., Duckers, J.
Publicado 2022

WS21.03 Low-cost chain termination DNA sequencing PCR reaction to diagnose CFTR gene mutations

por Ghani, M.U., Sabar, M.F., Awan, F.I.
Publicado 2022

ePS1.03 The impact of the COVID-19 lockdown and introduction of precision medication Symkevi and Orkambi on cystic fibrosis patients at Sheffield Children’s NHS Foundation Trust, U...

por Braisdell, K., West, N.S.
Publicado 2022

WS20.06 Co-infection with Nocardia farcinia and SARS-CoV-2 causing the death of an adolescent with cystic fibrosis

por Chapman, J., Gilchrist, F., Driscoll, S., Bakewell, K., Fishwick, R., Ho, S.-A., Carroll, W.
Publicado 2022